Search Results
Mar 31, 2026, 11:05 ET Biostime's New A-L-G Care™ Collection of Probiotic-enriched Supplements for Babies and Kids are Formulated with Clinically Studied Probiotic Strains Trusted by Scientific Experts to Help Strengthen Immunity, Support Skin Health, and Promote Nasal & Respiratory Wellness in Babies and Kids*
Baby & Kids Dual Defense Powder: https://www.youtube.com/watch?v=kL08o4mLWTc Follow this link to learn more from Dr. Lane about the science behind Biostime Baby & Kids Skin Defense Powder:
More news about: Biostime
Mar 23, 2026, 16:00 ET Pelican Intl Inc. Acquires KL Companies (KL Outdoor) to Accelerate Its Strategic Growth Plan and Consolidate Its Position as North America's Leading Paddlesports Platform
LAVAL, QC, March 23, 2026 /PRNewswire/ - Pelican Intl Inc. today announced the acquisition of The KL Companies, Inc. (KL Outdoor) of Muskegon, Michigan, marking a significant milestone in the execution of its strategic growth plan to build North America's most
More news about: Pelican Intl Inc.
Mar 23, 2026, 06:04 ET WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025
successfully passed FDA on-site inspections with no single observation. By year-end, our total reactor volume of small molecule APIs has reached over 4,000kL, while total reactor volume of Solid Phase Peptide Synthesizers has reached over 100,000L.Driving sustainability, embracing initiatives,
More news about: WuXi AppTec
Mar 21, 2026, 13:28 ET TTW Reveals Top 50 Safest Travel Destinations Around the World for 2026
heritage.Fly into Penang Airport (PEN) or travel from KL.3
More news about: Travel And Tour World
Mar 18, 2026, 11:22 ET 總生存期顯著延長：蘆康沙妥珠單抗(sac-TMT) OptiTROP-Lung03研究OS最終分析結果亮相
一款公司擁有自主智慧財產權的新型TROP2 ADC，針對NSCLC、乳腺癌(BC)、胃癌(GC)、婦科腫瘤等晚期實體瘤。蘆康沙妥珠單抗(sac-TMT)採用新型連接子進行開發，其通過偶聯一種貝洛替康衍生的拓撲異構酶I抑制劑作為有效載荷，藥物抗體比(DAR)達到7.4。蘆康沙妥珠單抗(sac-TMT)通過重組抗TROP2人源化單克隆抗體特異性識別腫瘤細胞表面的TROP2，其後被腫瘤細胞內吞併於細胞內釋放有效載荷KL610023。KL610023作為拓撲異構酶I抑制劑，可誘導腫瘤細胞DNA損傷，進而導致細胞週期阻滯及細胞凋亡。此外，其亦於腫瘤微環境中釋放KL610023。鑒於KL610023具有細
More news about: 科倫博泰
Mar 18, 2026, 10:27 ET Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study
cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable,
More news about: Kelun-Biotech
Mar 18, 2026, 05:03 ET Crocs™ brings KL Rahul on board as brand ambassador with 'Play Hard. Rest Easy.' Campaign
transition athletes make between moments of intensity and ease. In a playful nod to his initials, Rahul remarks, 'The 'KL' in KL Rahul stands for Keep Light and I am always KL-ing,' reflecting the energy and motion that define his life as a professional cricketer. The film closes on a playful note
More news about: Crocs India
Mar 16, 2026, 12:00 ET MiroMind Team Unveils MiroThinker-1.7 & MiroThinker-H1: A New Era of Verification-Centric Heavy-Duty Research Agents
trial-and-error refinement in live environments, with two critical innovations:Targeted Entropy Control: An auxiliary KL penalty is applied specifically to low-probability tokens in unsuccessful rollouts to sustain creative exploration and prevent premature convergence.Priority
More news about: MiroMind.ai
Mar 05, 2026, 11:58 ET Jeep® Brand Celebrates 85 Years of Unmatched 4x4 Capability and Adventure Leadership With Special Editions
WK-generation Jeep Grand Cherokee2007: The first four-door Jeep Wrangler debuts2014: The first Trailhawk-badged model debuts with KL-generation Cherokee2018: The first Jeep Trackhawk model debuts – the fastest Jeep ever, with a 707-horsepower HEMI V-82020: Jeep Gladiator
More news about: Stellantis
Mar 04, 2026, 09:00 ET Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development
the benefit of patients worldwide. With our state-of-the-art, CGMP-compliant facilities and operations based in China, Altruist Biologics offers a 60KL total capacity at its Suzhou site, which meets global regulatory standards from the NMPA, FDA, and EMA, and commenced partial operations at our Hangzhou
More news about: Altruist Biologics
Mar 04, 2026, 09:00 ET Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development
the benefit of patients worldwide. With our state-of-the-art, CGMP-compliant facilities and operations based in China, Altruist Biologics offers a 60KL total capacity at its Suzhou site, which meets global regulatory standards from the NMPA, FDA, and EMA, and commenced partial operations at our Hangzhou
More news about: Altruist Biologics
Feb 26, 2026, 14:30 ET Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
doi:10.1200/JCO.2020.38.15_suppl.e135927 Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population
More news about: Johnson & Johnson
Feb 24, 2026, 08:00 ET Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from the "anti-aging" human Klotho gene (s-KL), tissue-specific promoters, and novel tissue and organ delivery systems to transform and improve the treatment of neurodegenerative disorders such as
More news about: Klotho Neurosciences, Inc.
Feb 23, 2026, 01:00 ET The Perfect Travel Match: Wizzmoni partners with KL Rahul & Athiya Shetty
Wizzmoni, formerly Unimoni, has officially appointed Indian cricketer KL Rahul and Bollywood actor Athiya Shetty as the faces of its premium Wizz Voyager
More news about: Wizzmoni
Feb 20, 2026, 00:05 ET transcosmos achieves ISO 9001 certification in Malaysia
hubStandard: ISO 9001:2015Certificate Number: FS 829351Certified Office:Transcosmos (Malaysia) Sdn Bhd, KL Sentral, Kuala LumpurTranscosmos (Malaysia) Sdn Bhd, Sunway Velocity, Kuala LumpurTranscosmos (Malaysia) Sdn Bhd, Jalan Raja Chulan,
More news about: transcosmos inc.
Feb 18, 2026, 08:00 ET Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence
sequence encoding human the human s-KL protein for treating motor impairment. The claims also cover the use of neuronal cells and induced pluripotent stem cells (iPSC) containing the muscle-cell specific promoter and s-KL nucleic acid gene sequence encoding human the human s-KL protein and other cellular delivery
More news about: Klotho Neurosciences, Inc.
Feb 09, 2026, 11:33 ET WTWH Healthcare Announces Winners of 2025 Aspect Marketing & Advertising Awards
Brian Cavoli, Strategic Marketing Director, TributeEric Molho, Founder & Principal, Bon PartnersJim Lurie, Partner & Founder, o2kl advertisingJim Shaw, Healthcare Marketing LeaderJonah Blumenthal, Chief Marketing Officer, TypoDuctions and DRIFTKarla Pena
More news about: WTWH Media
Feb 06, 2026, 04:00 ET Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer
cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable,
More news about: Kelun-biotech
Feb 06, 2026, 04:00 ET 破局HR+/HER2-乳腺癌！蘆康沙妥珠單抗(sac-TMT)獲批第四項適應症
一款公司擁有自主智慧財產權的新型TROP2 ADC，針對非小細胞肺癌(NSCLC)、乳腺癌(BC)、胃癌(GC)、婦科腫瘤等晚期實體瘤。蘆康沙妥珠單抗(sac-TMT)採用新型連接子進行開發，其通過偶聯一種貝洛替康衍生的拓撲異構酶I抑制劑作為有效載荷，藥物抗體比(DAR)達到7.4。蘆康沙妥珠單抗(sac-TMT)通過重組抗TROP2人源化單克隆抗體特異性識別腫瘤細胞表面的TROP2，其後被腫瘤細胞內吞併於細胞內釋放有效載荷KL610023。KL610023作為拓撲異構酶I抑制劑，可誘導腫瘤細胞DNA損傷，進而導致細胞週期阻滯及細胞凋亡。此外，其亦於腫瘤微環境中釋放KL610023。鑒於KL6
More news about: 科倫博泰
Feb 05, 2026, 11:00 ET BougeRV Introduces the T1 Portable Camping Light: Built for the Wild, Powered for 12 Nights
our official website to enjoy the special pre-sale price of $69.99!https://bit.ly/45KL6p7About BougeRVBougeRV is dedicated to empowering outdoor adventurers with reliable, portable, and high-performance appliances.
More news about: BougeRV
Jan 21, 2026, 02:20 ET Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Rockville, Maryland, to further support supply resilience and proximity to clients. The site comprises two CGMP manufacturing plants with a combined 60 kL of drug substance capacity, supporting mid- to large-scale programs. The deal is expected to close in the first quarter of 2026, and the company intends
More news about: Samsung Biologics
Jan 18, 2026, 19:55 ET JAPAN SUI COLLECTION in Kyoto: Die Essenz japanischer Schönheit und Tradition in die Welt tragen - Bericht über die Veranstaltung im Gästehaus der Präfektur Kyoto
https://drive.google.com/file/d/1Pq5DhrSmhl6kl3pandogP8juYX-LfzrJ/view?usp=sharing Darbietungen & KulinarischesEine Modenschau von JUNKO KOSHINO und eine traditionelle „Kyogen"-Komödie
More news about: Cabinet Office, Government of Japan
Jan 16, 2026, 04:32 ET Astec LifeSciences to Showcase Manufacturing and ESG Leadership at PMFAI's ICSCE Dubai
includes nine world-class multipurpose plants engineered to handle complex and demanding chemistries. With flexible reactor capacities ranging from 3 KL to 32 KL across glass-lined, stainless steel and Hastelloy systems, Astec LifeSciences enables customers to scale efficiently while maintaining stringent
More news about: Astec LifeSciences
Jan 16, 2026, 04:16 ET Astec LifeSciences to Showcase Manufacturing and ESG Leadership at PMFAI's ICSCE Dubai
includes nine world-class multipurpose plants engineered to handle complex and demanding chemistries. With flexible reactor capacities ranging from 3 KL to 32 KL across glass-lined, stainless steel and Hastelloy systems, Astec LifeSciences enables customers to scale efficiently while maintaining stringent
More news about: Astec LifeSciences
Jan 13, 2026, 21:14 ET JAPAN SUI COLLECTION en Kioto: Llevando la esencia de la belleza y la tradición japonesas al mundo
https://drive.google.com/file/d/1Pq5DhrSmhl6kl3pandogP8juYX-LfzrJ/view?usp=sharing Espectáculos y gastronomíaUn desfile de moda de JUNKO KOSHINO y una representación teatral
More news about: Cabinet Office, Government of Japan